134 related articles for article (PubMed ID: 20712782)
1. Predicting pituitary iron and endocrine dysfunction.
Wood JC; Noetzl L; Hyderi A; Joukar M; Coates T; Mittelman S
Ann N Y Acad Sci; 2010 Aug; 1202():123-8. PubMed ID: 20712782
[TBL] [Abstract][Full Text] [Related]
2. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients.
Hekmatnia A; Radmard AR; Rahmani AA; Adibi A; Khademi H
Acta Radiol; 2010 Feb; 51(1):71-7. PubMed ID: 20001472
[TBL] [Abstract][Full Text] [Related]
4. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
5. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
7. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
8. Pituitary Iron Deposition and Endocrine Complications in Patients with β-Thalassemia: From Childhood to Adulthood.
Karadag SIK; Karakas Z; Yilmaz Y; Gul N; Demir AA; Bayramoglu Z; Darendeliler F; Dursun M
Hemoglobin; 2020 Sep; 44(5):344-348. PubMed ID: 32900239
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
[TBL] [Abstract][Full Text] [Related]
10. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
[TBL] [Abstract][Full Text] [Related]
11. Utility of MRI in assessment of pituitary iron overload.
Zafar AM; Zuberi L; Khan AH; Ahsan H
J Pak Med Assoc; 2007 Sep; 57(9):475-7. PubMed ID: 18072648
[TBL] [Abstract][Full Text] [Related]
12. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
Kumar P; Jagannathan NR; Choudhry VP
J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
Porter JB
Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
[TBL] [Abstract][Full Text] [Related]
14. High nontransferrin bound iron levels and heart disease in thalassemia major.
Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
[TBL] [Abstract][Full Text] [Related]
15. The investigation of gingival iron accumulation in thalassemia major patients.
Calişkan U; Tonguç MO; Ciriş M; Balta N; Kirzioglu FY; Caglayan G; Canatan D
J Pediatr Hematol Oncol; 2011 Mar; 33(2):98-102. PubMed ID: 21285897
[TBL] [Abstract][Full Text] [Related]
16. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
17. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients.
Taher AT; Musallam KM; Wood JC; Cappellini MD
Am J Hematol; 2010 Apr; 85(4):288-90. PubMed ID: 20143405
[No Abstract] [Full Text] [Related]
19. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
[TBL] [Abstract][Full Text] [Related]
20. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
